Only 20% of people covered by Medicaid received treatment within six months of their HCV diagnosis.

With Campbell Foundation funding, a Wistar Institute scientist studies ways to engineer immune cells to attack HIV-infected cells.

The vaccine, dubbed VIR-1388, is designed to stimulate the production of T cells to fight HIV.

Study findings identify a potential marker that could help identify people at high risk of developing long COVID.

People with repeat monkeypox infections and those who were vaccinated are less likely to develop severe symptoms.

Certain drugs in this class may increase the likelihood of diabetes and hypertension, but cardiovascular risk factors can be managed.

Studies highlight the need for better prevention and management of age-related health problems.

Research on the links between tenofovir and other antiretrovirals, SARS-CoV-2 infection and COVID severity has produced mixed results.

U.S. syphilis incidence has increased since 2000, with an escalating toll in medically underserved populations.